1. Home /
  2. Latest


Stop Wishing, Hoping and Praying and Take Control of Your Investing

The most powerful thing an investor can do is embrace the idea that they don't know what the future holds.

If You've Got Time, These Three Dividend Aristocrats Should Pay Off

There high-growth dividend stocks will be here over the long haul.

Welcome to Second Semester on Wall Street, Here's How to Make the Grade

Think you can own big tech? You might just get an 'F' for that. Here's what will get you on the other side of this year.

We Got a Break, but the Heat Is Still On

A limited rally cooled some of the negativity on the market, but guess what's going to hit the fan soon?

Coupang Could Make a Bigger Trading Bounce

Here's where nimble traders could probe the long side.

Does Halozyme Therapeutics, My Q2 Pick, Still Have a HALO Over It?

Let's check the charts on this biotechnology stock and see if it still has a prayer.

Shares of Xencor Could Be Bought on a 50% Correction

Traders should remain patient.

Let's Size Up the Market's Prospects for the Second Half of 2022

The next six months can't be worse than the first six, can they?

In an Ugly First Half for Stocks, Value Was a Lot Less Ugly Than Growth

A look at the Russell indexes shows that value stocks suffered in the first six months of 2022 but not nearly as much as growth issues.

Nuvalent Has Begun the Bottoming Process

Let's check the charts and indicators.

You Can Invest in Micron, But Here's Why You May Want to Wait

MU reported earnings Thursday night and the guidance was shocking.

The Charts Point to More Selling Ahead for 4 Former Tech Leaders

Keep in mind that no matter how much a stock has fallen, it can always go lower, and it appears these four stocks could prove that point.

Enanta Pharmaceuticals Bounces Off a Key Support Level Once Again

The shares of the biotech company appear to be finding a bottom but could use more sideways action to create a better base.

CRISPR Therapeutics Has Turned the Corner

Here's our current price target.

A Few Thoughts on How to Approach a Tougher Bear Market Than Most

A key goal is to keep from losing money while the current bear runs its course, and don't count on positive seasonality leading to the Fourth of July.

Four Things I Know for Sure About the Market

As the second half of 2022 begins, keep this quarter of observations in mind.

Little-Known Akoya Biosciences Appears to Have Found a Bottom

The stock of the life sciences company has found buying interest at a key support level.

Hong Kong Marks 25 Years Since Handover With New Version of History

Just don't call it a handover - Chinese President Xi Jinping has been on a whistle-stop tour of Hong Kong, which we're now told never belonged to the British.

Welcome Break, Sellers at the Ready, Defense on Offense, GDP Sags, Yield Watch

Plus, disappointing personal spending figures and an explanation of how the Fed views inflation (hint: it isn't how you view it).

This Year Has Been Ugly. Here's a Trick to Make Up Some of the Damage

Let's look at the incredible value of Roth conversions, during trying times.

The Market, It's Such a Gas!

Commodities like gas came down and people finally noticed. Let's check on that diesel, 30-year bonds and more.

Warning: Watch for Bull Trap

After an ugly day of bear market trading, beware of what could hide ahead on Friday.

For This REIT It's All About That Base

We're checking the charts and indicators on Ventas, owner of senior housing and medical facilities.

This ETF Boasts 'Inflation Protection,' but Will It Rise to the Occasion?

The Ionic Inflation Protection exchange-traded fund, the latest such ETF to hit the market, offers direct exposure to the consumer price index.

Want to Save Your Retirement Fund? Tune Out the Talking Heads

The first half of this year has been ugly. But we could have seen what would happen to Netflix, Tesla and Meta...

Is Pinterest's CEO Change Good News? It Depends on How You Look at It

Plus, why a report about an Apple 5G modem setback sounds believable.

National Health Investors Is Aging Well as It Emerges From a Base Formation

Buyers of the shares are becoming more aggressive.

As Carnival, Royal Caribbean and Norwegian Sink, Here's When to Dive In

These stocks are priced for an industry-wide calamity, but how realistic is that considering their customer base?

General Mills Is Seeing New Highs on the Charts

Here's what traders looking to go long GIS could do.

Constellation Brands Gaps Lower Despite Earnings Beat

Is this a buying opportunity or the start of a deeper decline?